Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Casopitant for Prevention of Postoperative Nausea and Vomiting
NCT00334152Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2006
- Primary completion
- Jul 2006
- Countries
- 11
01
Overview
A Phase 3 trial of casopitant in postoperative nausea and vomiting (PONV), sponsored by GSK. Started Mar 2006; status: completed.
02
Drugs
casopitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT00334152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334152.